Z-D-Dap(Fmoc)-OH is a protected, stereochemically specified amino acid derivative of D-2,3-diaminopropanoic acid (Dap) bearing both a benzyloxycarbonyl (Z, Cbz) protecting group and an Fmoc protecting group on the side-chain amino functionality. The molecule contains a free carboxylic acid group (-COOH) and an amino acid backbone, while the side-chain amines are masked to control chemoselectivity during peptide assembly and to reduce undesired side reactions. Z-D-Dap(Fmoc)-OH is used as a building block for stepwise peptide synthesis and related chemical biology workflows where orthogonally protected diamino acid residues are incorporated into peptides or employed for preparing further amino acid and peptide derivatives.
CAT No: CP25496
CAS No:185968-90-5
Synonyms/Alias:N-alpha-Z-N-beta-Fmoc-D-2,3-diaminopropionic acid;Z-D-Dpr(Fmoc)-OH;Z-D-Dapa(Fmoc)-OH
Chemical Name:N-alpha-Benzyloxycarbonyl-N-beta-(9-fluorenylmethyloxycarbonyl)-D-2,3-diaminopropionic acid
1. Cationic cell-penetrating peptides are potent furin inhibitors
2. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review
3. Implications of ligand-receptor binding kinetics on GLP-1R signalling
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More